The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

U.S. District Judge Kenneth Bell, who is overseeing the Gardasil multidistrict litigation in the Western District of North Carolina, sided with Merck on its implied preemption defense, granting ...

A fascinated group of Irvine youngsters were treated to an insightful visit from a major business based in the town this month.

The incidence of and mortality from cervical cancer are higher among rural-residing women versus their urban counterparts ...

Kennedy can provide doctors and healthcare professionals with the information they need to truly determine if a drug is safe, ...

Moderna (NASDAQ:MRNA) is targeting market approval of a personalized vaccine the company is developing with Merck (NYSE:MRK) ...

After several dashed predictions, quantum computing is accelerating rapidly with actual use cases and scientific ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...